Medical Marijuana Inc. recently released the results of a clinical trial involving CBD-based Real Scientific Hemp Oil for relief from Lennox Gastaut Syndrome (LGS). LGS is described as severe childhood encephalopathy that produces frequent seizures and cognitive impairment, and it had previously been considered treatment-resistant to conventional therapies. Recently, however, researchers have found CBD to be a more successful treatment option. This new study from Medical Marijuana Inc. found RHSO-X 5000 reduced seizures for 84% of their patients, and over half of the patients reported their seizures reduced by 75%. Another 17% of patients reported becoming seizure free. Additionally, 89% of patients reported an improved quality of life without experiencing negative or severe side effects.
This information has been provided by Merry Jane and approved by our Chief Medical Officer.